Factor Update, February 22, 2025
This content is for members only
Source link
This content is for members only
Source link
Maxim Group reduced their target price on shares of INmune Bio from $30.00 to $8.00 and set a “buy” rating for the company in a report on Wednesday. Source link
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:”Table Normal”; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:””; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0in; line-height:115%; mso-pagination:widow-orphan; font-size:12.0pt; font-family:”Aptos”,sans-serif; mso-ascii-font-family:Aptos; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Aptos; mso-hansi-theme-font:minor-latin; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual;} December S&P E-mini futures: Inflation is coming down and the Fed has started to lower rates. A…
π Smart Exit Management Without Stop Loss β for Grid & Recovery Strategies If you’ve ever traded with a grid or martingale system, you know the pain: π Multiple open trades in drawdown π No stop loss π And no clear way out… Thatβs exactly why we built the π― ClosePositionType System Itβs a smart…
This content is for members only Source link
GBP/JPY β Nice Range Opportunity Source link
Source: Investor Presentation of INOXGFL Group Source link